Topoisomerase 2 alpha as a predictor of response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer

被引：0
|
作者：
M Shehata
A Al-Attar
J Reis-Filho
I Ellis
A Mukherjee
S Chan
机构：
[1] Nottingham University Hospital,The Breakthrough Breast Cancer Research Centre
[2] Institute of Cancer Research,undefined
来源：
Breast Cancer Research | / 12卷
关键词：
Breast Cancer; Breast Cancer Patient; Cyclophosphamide; Fluorouracil; Anthracyclines;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Topoisomerase 2 alpha as a predictor of response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer
    Shehata, M.
    Al-Attar, A.
    Reis-Filho, J.
    Ellis, I.
    Mukherjee, A.
    Chan, S.
    [J]. BREAST CANCER RESEARCH, 2010, 12 : S14 - S15
  • [2] The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients
    Stamatovic, Ljiljana
    Susnjar, Snezana
    Gavrilovic, Dusica
    Minic, Ivana
    Ursulovic, Tamara
    Dzodic, Radan
    [J]. JOURNAL OF BUON, 2018, 23 (05): : 1273 - 1280
  • [3] The influence of breast cancer subtypes on response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients
    Susnjar, S.
    Stamatovic, L.
    Gavrilovic, D.
    Minic, I.
    Ursulovic, T.
    [J]. BREAST, 2017, 32 : S81 - S82
  • [4] Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer
    Fernández-Sánchez, M
    Gamboa-Dominguez, A
    Uribe, N
    García-Ulloa, AC
    Flores-Estrada, D
    Candelaria, M
    Arrieta, O
    [J]. MEDICAL ONCOLOGY, 2006, 23 (02) : 171 - 183
  • [5] Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer
    Mónica Fernández-Sánchez
    Armando Gamboa-Dominguez
    Norma Uribe
    Ana Cristina García-Ulloa
    Diana Flores-Estrada
    Myrna Candelaria
    Oscar Arrieta
    [J]. Medical Oncology, 2006, 23 : 171 - 183
  • [6] Tumor Topoisomerase II Alpha Status and Response to Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer
    Nikolenyi, Aliz
    Suekoesd, Farkas
    Kaizer, Laszlo
    Csoergo, Erika
    Voeroes, Andras
    Uhercsak, Gabriella
    Ormandi, Katalin
    Lazar, Gyoergy
    Thurzo, Laszlo
    Brodowicz, Thomas
    Kahan, Zsuzsanna
    [J]. ONCOLOGY, 2011, 80 (3-4) : 269 - 277
  • [7] The role of topoisomerase II-α (TOPO IIA) as a predictive factor for response to neoadjuvant anthracycline-based chemotherapy in locally advanced breast cancer
    Gamea, M. M.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 28 - 28
  • [8] The role of topoisomerase II-α (TOPO IIA) as a predictive factor for response to neoadjuvant anthracycline-based chemotherapy in locally advanced breast cancer
    Gamea, M.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 33 - 33
  • [9] Neo-adjuvant anthracycline based chemotherapy in locally advanced breast cancer: assessment of topoisomerase IIA with response
    Singer, J.
    Dewdney, A.
    Mapp, L.
    Bradpiece, H. A.
    Jenkins, S.
    Jader, S.
    Patel, A.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 311 - 311
  • [10] Taxane and Anthracycline Based Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer : Institutional Experience
    Gogia, Ajay
    Raina, Vinod
    Deo, Suryanarayan Vishnu
    Shukla, Nootan Kumar
    Mohanti, Bidhu Kalyan
    Sharma, Daya Nand
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (05) : 1989 - 1992
12345